BANK OF AMERICA CORP /DE/
BankPosition in TSHA — Taysha Gene Therapies, Inc.
CIK 70858
CHARLOTTE, NC
Position in TSHA
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$7,496,394
+$1,156,655 QoQ
Shares Held
1,677,046
+45.5% QoQ
Ownership
0.584%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TSHA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,750,242 across 347 Biotechnology names. TSHA ranks #117 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in TSHA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,496,394 | 1,677,046 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $6,339,739 | 1,152,680 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $4,274,827 | 1,307,287 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $1,687,981 | 730,728 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $885,209 | 636,842 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,958,823 | 1,710,303 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $268,806 | 133,735 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $277,700 | 123,974 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $360,795 | 125,713 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $216,520 | 122,328 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $120,648 | 38,180 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $19,453 | 29,431 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $109,326 | 137,001 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $113,849 | 50,376 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $134,143 | 69,505 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $245,678 | 66,043 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $465,253 | 71,358 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $718,174 | 61,646 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $608,444 | 32,677 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $516,834 | 24,379 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $301,556 | 14,855 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $173,996 | 6,556 | Shares | Defined | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||